SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-19-222574
Filing Date
2019-08-15
Accepted
2019-08-15 17:11:02
Documents
2
Group Members
ANDREW G. BLUHMDSC ADVISORS, L.L.C.DSC ADVISORS, L.P.DSC MANAGERS, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G d541713dsc13g.htm SC 13G 95894
2 EX-99.1 d541713dex991.htm EX-99.1 9056
  Complete submission text file 0001193125-19-222574.txt   106704
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Subject) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88525 | Film No.: 191031009
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 900 N. MICHIGAN, SUITE 1600 CHICAGO IL 60611
Business Address 900 N. MICHIGAN, SUITE 1600 CHICAGO IL 60611 312-915-2886
Delaware Street Capital Master Fund, L.P. (Filed by) CIK: 0001648576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G